Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 22 (4), 329-36

Zafirlukast (Accolate): A New Treatment for Capsular Contracture

Zafirlukast (Accolate): A New Treatment for Capsular Contracture

S Larry Schlesinger et al. Aesthet Surg J.


Background: Capsular contracture after breast augmentation or reconstructive breast surgery is a difficult problem. Previous studies have suggested that alteration of the inflammatory response could have a role in reducing the incidence of capsular contracture.

Objective: We report a series of patients with Baker class III or IV capsular contracture who underwent treatment with zafirlukast.

Methods: Patients received a regimen of zafirlukast 20 mg by mouth 2 times daily for 3 months.

Results: In many cases, dramatic softening of the breast capsule was evident after 1 to 3 months of treatment.

Conclusions: Zafirlukast appears to effectively soften early capsular contracture and may prevent the formation of capsular contracture in those patients at risk. (Aesthetic Surg J 2002;22:329-336.).

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources